Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;5(2):81-86.
doi: 10.1142/S2339547817500042.

Hypoxia Impairs Mesenchymal Stromal Cell-Induced Macrophage M1 to M2 Transition

Renea A Faulknor  1 , Melissa A Olekson  1 , Emmanuel C Ekwueme  1 , Paulina Krzyszczyk  1 , Joseph W Freeman  1 , François Berthiaume  1
Affiliations

Hypoxia Impairs Mesenchymal Stromal Cell-Induced Macrophage M1 to M2 Transition

Renea A Faulknor et al. Technology (Singap World Sci). 2017 Jun.

Abstract

The transition of macrophages from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype is crucial for the progression of normal wound healing. Persistent M1 macrophages within the injury site may lead to an uncontrolled macrophage-mediated inflammatory response and ultimately a failure of the wound healing cascade, leading to chronic wounds. Mesenchymal stromal cells (MSCs) have been widely reported to promote M1 to M2 macrophage transition; however, it is unclear whether MSCs can drive this transition in the hypoxic environment typically observed in chronic wounds. Here we report on the effect of hypoxia (1% O2) on MSCs' ability to transition macrophages from the M1 to the M2 phenotype. While hypoxia had no effect on MSC secretion, it inhibited MSC-induced M1 to M2 macrophage transition, and suppressed macrophage expression and production of the anti-inflammatory mediator interleukin-10 (IL-10). These results suggest that hypoxic environments may impede the therapeutic effects of MSCs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
LPS augments macrophage and MSC secretion. Immobilized MSCs or M1 macrophages were cultured with or without LPS for 48 hours under normoxia or hypoxia. (A) TNF-α and IL-10 proteins secreted by macrophages. N=4; *:p<0.0001 compared to no LPS (B) TNF-α, IL-10, PGE2, and TGF-β1 secreted by MSCs. N=3 – 6; *:p<0.0001 compared to no LPS.
Fig. 2
Fig. 2
Hypoxia regulates macrophage function. LPS-stimulated M1 macrophages were cultured for 48 hours under normoxia or hypoxia. (A) HIF-1α protein expression in macrophages was determined by Western blot. GAPDH was used as the loading control. (B) Percent macrophage viability was determined by fluorescent live/dead staining. Calcein AM+/EthD-1− cells were deemed viable. N=3. (C) PGE2 secreted by MSCs. N=4. (D) TNF-α, IL-10, and IDO gene expressions by macrophages. N=4; *:p=0.05.
Fig. 3
Fig. 3
MSCs upregulate CD206 expression on macrophages. LPS-stimulated M1 macrophages were cultured in MSC-conditioned medium or sham-conditioned medium for 48 hours under normoxia or hypoxia. (A) CD206 (M2 macrophage marker) expression in macrophages was examined by fluorescent microscopy. Scale bar = 20μm. Quantification of CD206+ cells. N=6; **:p<0.0001 compared to both MSC groups under normoxia; +:p<0.01 compared to MSC-CM group under hypoxia; *:p<0.001.
Fig. 4
Fig. 4
MSCs induce an M2 secretion profile by macrophages. M1 macrophages were co-cultured with MSCs for 48 h under normoxia or hypoxia. (A) TNF-α protein secreted by macrophages. N=6; *:p<0.0001 compared to both MSC groups and the PGE2 group in both normoxia and hypoxia. +:p<0.05 compared to both MSC groups. #:p<0.05. (B) IL-10 protein secreted by macrophages. N=6; *:p<0.0001 compared to both MSC groups and the PGE2 group in normoxia. +:p<0.01 compared to both MSC groups and the PGE2 group in hypoxia. (C) TGF-β1 protein secreted by macrophages. N=6; *:p<0.001 compared to both MSC groups and the PGE2 group in normoxia. +:p<0.01 compared to both MSC groups and the PGE2 group in hypoxia.
See this image and copyright information in PMC

References

    1. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289. - PubMed
    1. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383–396. - PubMed
    1. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, Weiss JM, Wlaschek M, Sunderkotter C, Scharffetter-Kochanek K. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121:985–997. - PMC - PubMed
    1. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I, Costa H, Canones C, Raiden S, Vermeulen M, Geffner JR. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010;5:e9252. - PMC - PubMed
    1. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42–49. - PMC - PubMed

LinkOut - more resources